JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker

  • 0Graduate School, Dalian Medical University, Dalian, Liaoning, China.
Discover Oncology +

|

August 1, 2024

|

August 1, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Collagen XV alpha 1 (COL15A1) shows varied expression and prognostic correlations across 33 tumor types. This collagen may impact tumor immunity, suggesting its potential as a pan-cancer prognostic marker.

Area Of Science

  • Oncology
  • Molecular Biology
  • Immunology

Background

  • Collagen type XV alpha 1 (COL15A1) is part of the collagen superfamily and influences disease progression via immune pathways.
  • While COL15A1's role in specific cancers is recognized, a comprehensive pan-cancer analysis is lacking.
  • Understanding COL15A1's broader impact is crucial for cancer research and therapeutic strategies.

Purpose Of The Study

  • To conduct a pan-cancer assessment of Collagen type XV alpha 1 (COL15A1) across 33 tumor types.
  • To investigate the potential oncogenic role and immune function of COL15A1 in malignancies.
  • To explore COL15A1 as a potential prognostic biomarker in diverse cancers.

Main Methods

  • Utilized bioinformatics approaches to analyze COL15A1 expression, tumor prognosis, microsatellite instability (MSI), tumor mutational burden (TMB), and single nucleotide polymorphism (SNP).
  • Assessed drug sensitivity, immune cell infiltration, and the correlation between cancer stem cells (CSCs) and COL15A1 expression.
  • Performed a comprehensive pan-cancer analysis across 33 distinct tumor types.

Main Results

  • COL15A1 was highly expressed in most investigated tumors.
  • COL15A1 exhibited diverse prognostic correlations (both positive and negative) across different tumor types.
  • Significant associations were found between COL15A1 expression and MSI, TMB, and immune-infiltrating cells.

Conclusions

  • COL15A1 plays a differential role in the progression of various cancers.
  • COL15A1's significant correlation with tumor immunity markers suggests its involvement in cancer immune response.
  • COL15A1 demonstrates potential as a pan-cancer prognostic biomarker due to its varied expression and immune functions.

Keywords: